Rehal, Sunita

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Boeree, M. J., Heinrich, N., Aarnoutse, R., Diacon, A. H., Dawson, R., Rehal, S., Kibiki, G. S., Churchyard, G., Sanne, I., Ntinginya, N. E., et al. (2017) · The Lancet Infectious Diseases

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 379

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis

Klein, G., Delmar, P., Voyle, N., Rehal, S., Hofmann, C., Abi-Saab, D., Andjelkovic, M., Ristic, S., Wang, G., Bateman, R., et al. (2019) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 212

Risk of selection bias in randomised trials

Kahan, B. C., Rehal, S., & Cro, S. (2015) · Trials

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 180

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials

Kahan, B. C., Cro, S., Doré, C. J., Bratton, D. J., Rehal, S., Maskell, N. A., Rahman, N., & Jairath, V. (2014) · Trials

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 123

Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands

Cro, S., Kahan, B. C., Rehal, S., Chis Ster, A., Carpenter, J. R., White, I. R., & Cornelius, V. R. (2022) · BMJ

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 52